Clinical Trials Browser

Interventional × Endometrial Neoplasms × pelcitoclax × Clear all

NCT05691504 2026-03-19

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Phase 1 Recruiting

GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Endometrial Neoplasms